On the sites of antitussive action of dl-glaucine phosphate.
The sites of antitussive action of dl-1,2,9,10-tetramethoxy-6a,alpha-aporphine phosphate (dl-glaucine phosphate, DL-832) were studied. It was assumed from the following results that DL-832 acts on the cough center per se. a) When DL-832 was given by the routes leading to the brain stem such as the vertebral artery and the cerebello-medullary cistern, far smaller doses were sufficient to obtain the same effect as that by i.v. administration. b) DL-832 showed neither effect on the afferent pathway for cough reflex nor influence on pulmonary stretch receptors. c) It exhibited practically no influence on the efferent pathways for cough reflex, that is, that for innervating respiratory muscle movement as well as that for controlling bronchial muscle tone. d) Decerebration exerted no influence on the antitussive effect. e) DL-832 definitely depressed the potentials of both the recurrent and internal intercostal nerves evoked by the superior laryngeal nerve stimulation. f) In deafferentated and decerebrate cats, DL-832 rather increased the spontaneous discharges of the phrenic nerve, whereas codeine decreased them.
D000344:Afferent Pathways / Q000187:drug effects; D000818:Animals; D000996:Antitussive Agents; D001060:Aporphines / Q000008:administration & dosage / Q000494:pharmacology*; D002415:Cats; D003655:Decerebrate State; D004558:Electric Stimulation; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D006168:Guinea Pigs; D007823:Laryngeal Nerves / Q000187:drug effects; D008297:Male; D010791:Phrenic Nerve / Q000502:physiology; D011311:Pressoreceptors / Q000187:drug effects
D000996:Antitussive Agents; D001060:Aporphines; C005004:glaucine